🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines Trump’s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines Trump’s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications
Updated 04 Jul 2026 · HPRA open data

Exeltis Healthcare S.L. — Licensed Medicines

7 medicines held by Exeltis Healthcare S.L. on the Irish market, from the HPRA register of authorised products.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9
← All medicines · 7 products held by Exeltis Healthcare S.L.
MedicineActive substanceLicence holderStatus
Doxpirexel 20 mg/ 20 mg modified-release tablets
PA22998/004/001
Pyridoxine hydrochloride, Doxylamine hydrogen succinate Exeltis Healthcare S.L. Not marketed
Doxylamine/Pyridoxine Exeltis 10 mg/10 mg gastro-resistant tablets
PA22998/001/001
Pyridoxine hydrochloride, Doxylamine hydrogen succinate Exeltis Healthcare S.L. Not marketed
Doxylamine/Pyridoxine Exeltis Healthcare 20mg/ 20mg modified-release tablets
PA22998/005/001
Doxylamine hydrogen succinate, Pyridoxine hydrochloride Exeltis Healthcare S.L. Not marketed
Kelzy 2 mg/0.02 mg prolonged release tablets
PA22998/007/001
Dienogest, Ethinylestradiol Exeltis Healthcare S.L. Not marketed
Slyndy 4 mg film-coated tablets
PA22998/002/001
Drospirenone Exeltis Healthcare S.L. Not marketed
Xonvea 10 mg/10 mg gastro-resistant tablets
PA22998/006/001
Pyridoxine hydrochloride, DOXYLAMINE SUCCINATE Exeltis Healthcare S.L. Not marketed
Xonvea MR 20 mg/20 mg modified-release tablets
PA22998/003/001
Doxylamine hydrogen succinate, Pyridoxine hydrochloride Exeltis Healthcare S.L. Not marketed
Cite this database

Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 13 August 2026).

Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.